Literature DB >> 12243798

Nitric oxide in respiratory diseases.

B J Nevin1, K J Broadley.   

Abstract

The formation and modulation of nitric oxide (NO) in the lungs is reviewed. Its beneficial and deleterious roles in airways diseases, including asthma, chronic obstructive pulmonary disease, and cystic fibrosis, and in animal models is discussed. The pharmacological effects of agents that modulate NO production or act as NO donors are described. The clinical pharmacology of these agents is described and the therapeutic potential for their use in airways disease is considered.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12243798     DOI： 10.1016/s0163-7258(02)00262-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


  6 in total

1.  Nitric oxide metabolites as biomarkers for influenza-like acute respiratory infections presenting to the emergency room.

Authors:  Asad I Mian; Federico R Laham; Andrea T Cruz; Harsha Garg; Charles G Macias; A Chantal Caviness; Pedro A Piedra
Journal:  Open Respir Med J       Date:  2012-11-14

2.  Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.

Authors:  Joan P Blonder; Sarah C Mutka; Xicheng Sun; Jian Qiu; Lucia H Green; Navdeep K Mehra; Ramakrishna Boyanapalli; Michael Suniga; Kirsten Look; Chris Delany; Jane P Richards; Doug Looker; Charles Scoggin; Gary J Rosenthal
Journal:  BMC Pulm Med       Date:  2014-01-10       Impact factor: 3.317

3.  Arginine and nitric oxide pathways in obesity-associated asthma.

Authors:  Fernando Holguin
Journal:  J Allergy (Cairo)       Date:  2013-04-21

4.  Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making.

Authors:  Asad I Mian; Mayank Aranke; Nathan S Bryan
Journal:  Open Biochem J       Date:  2013-03-08

Review 5.  Host defense function of the airway epithelium in health and disease: clinical background.

Authors:  Simon D Message; Sebastian L Johnston
Journal:  J Leukoc Biol       Date:  2003-09-12       Impact factor: 4.962

6.  A Biomarker-Based Approach to Infectious Disease in the Pediatric Emergency Department.

Authors:  Mayank Aranke; Asad I Mian
Journal:  Clin Pediatr Emerg Med       Date:  2013-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.